» Articles » PMID: 25743370

Uroguanylin Levels in Intestine and Plasma Are Regulated by Nutritional Status in a Leptin-dependent Manner

Overview
Journal Eur J Nutr
Date 2015 Mar 7
PMID 25743370
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Uroguanylin (UGN) is a 16 amino acid peptide produced mainly by intestinal epithelial cells. Nutrients intake increases circulating levels of prouroguanylin that is processed and converted to UGN to activate the guanylyl cyclase 2C receptor (GUCY2C). Given that the UGN-GUCY2C system has been proposed as a novel gut-brain endocrine axis regulating energy balance, the aim of the present study was to investigate the regulation of UGN protein levels in duodenum and circulating levels in lean and obese mice under different nutritional conditions and its potential interaction with leptin.

Methods: Swiss, C57BL/6 wild-type and ob/ob male adult mice under different nutritional conditions were used: fed ad libitum standard diet (control); 48 h fasting (fasted); 48 h fasting followed by 24 h of feeding (refed); and fed high-fat diet (45 %) during 10 weeks. In addition, peripheral leptin administration was performed. Intestinal uroguanylin expression was studied by Western blot analysis; plasma levels were measured by ELISA.

Results: Food deprivation significantly reduced plasma UGN levels, which were correlated with the lower protein levels of UGN in duodenum. These effects were reverted after refeeding and leptin challenge. Consistently, in ob/ob mice UGN expression was decreased, whereas leptin treatment up-regulated UGN levels in duodenum in these genetically modified mice compared to WT. Diet-induced obese mice displayed increased UGN levels in intestine and plasma in comparison with lean mice.

Conclusions: Our findings suggest that UGN levels are correlated with energy balance status and that the regulation of UGN by nutritional status is leptin-dependent.

Citing Articles

The Important Role of Aquaglyceroporin 7 in Health and Disease.

Liu J, Xia Z, Peng S, Xia J, Xu R, Wang X Biomolecules. 2024; 14(10).

PMID: 39456161 PMC: 11505742. DOI: 10.3390/biom14101228.


Receptor Guanylyl Cyclase C and Cyclic GMP in Health and Disease: Perspectives and Therapeutic Opportunities.

Prasad H, Mathew J, Visweswariah S Front Endocrinol (Lausanne). 2022; 13:911459.

PMID: 35846281 PMC: 9276936. DOI: 10.3389/fendo.2022.911459.


Lipoabdominoplasty and the leptin hormone.

Ghafoor L, Entezari V, Fallah A, Hajian A Ann Med Surg (Lond). 2021; 68:102633.

PMID: 34386225 PMC: 8346541. DOI: 10.1016/j.amsu.2021.102633.


MECHANISMS IN ENDOCRINOLOGY: The gut-brain axis: regulating energy balance independent of food intake.

Nogueiras R Eur J Endocrinol. 2021; 185(3):R75-R91.

PMID: 34260412 PMC: 8345901. DOI: 10.1530/EJE-21-0277.


Activation of brown adipose tissue in diet-induced thermogenesis is GC-C dependent.

Habek N, Dobrivojevic Radmilovic M, Kordic M, Ilic K, Grgic S, Farkas V Pflugers Arch. 2020; 472(3):405-417.

PMID: 31940065 DOI: 10.1007/s00424-020-02347-8.


References
1.
Valentino M, Lin J, Snook A, Li P, Kim G, Marszalowicz G . A uroguanylin-GUCY2C endocrine axis regulates feeding in mice. J Clin Invest. 2011; 121(9):3578-88. PMC: 3223926. DOI: 10.1172/JCI57925. View

2.
Tschop M, Smiley D, Heiman M . Ghrelin induces adiposity in rodents. Nature. 2000; 407(6806):908-13. DOI: 10.1038/35038090. View

3.
Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K . Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999; 402(6762):656-60. DOI: 10.1038/45230. View

4.
Carrithers S, Barber M, Biswas S, Parkinson S, Park P, Goldstein S . Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues. Proc Natl Acad Sci U S A. 1996; 93(25):14827-32. PMC: 26221. DOI: 10.1073/pnas.93.25.14827. View

5.
Carrithers S, Parkinson S, Goldstein S, Park P, ROBERTSON D, Waldman S . Escherichia coli heat-stable toxin receptors in human colonic tumors. Gastroenterology. 1994; 107(6):1653-61. DOI: 10.1016/0016-5085(94)90804-4. View